SUSMED,Inc. (TYO:4263)
Japan · Delayed Price · Currency is JPY 469.00
-100.00 (-17.57%)
Aug 27, 2026, 1:18 PM JST
SUSMED,Inc. Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 3,698 | 4,398 | 4,846 | 5,048 | 4,904 |
Cash & Short-Term Investments | 3,698 | 4,398 | 4,846 | 5,048 | 4,904 |
Cash Growth | -15.92% | -9.25% | -4.00% | 2.94% | 201.60% |
Accounts Receivable | 273 | 15 | 10 | 10 | 9 |
Other Receivables | - | - | 9 | - | - |
Receivables | 273 | 15 | 19 | 10 | 9 |
Prepaid Expenses | 49 | 47 | 30 | 25 | 21 |
Other Current Assets | 7 | 2 | 3 | 2 | 1 |
Total Current Assets | 4,027 | 4,462 | 4,898 | 5,085 | 4,935 |
Property, Plant & Equipment | 6 | - | - | - | - |
Long-Term Investments | 95 | 24 | 25 | 8 | 8 |
Other Intangible Assets | 88 | 16 | 8 | 7 | - |
Other Long-Term Assets | 2 | - | 1 | 1 | - |
Total Assets | 4,218 | 4,502 | 4,932 | 5,101 | 4,943 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | - | 1 | - | - | - |
Accrued Expenses | 7 | 1 | 1 | 1 | 1 |
Current Income Taxes Payable | 81 | 71 | 67 | 82 | 70 |
Other Current Liabilities | 59 | 52 | 253 | 141 | 16 |
Total Current Liabilities | 147 | 125 | 321 | 224 | 87 |
Other Long-Term Liabilities | 1 | 7 | 7 | 7 | 6 |
Total Liabilities | 148 | 132 | 328 | 231 | 93 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 10 | 99 | 80 | 40 | 1,853 |
Additional Paid-In Capital | 5,566 | 5,441 | 5,423 | 5,383 | 3,509 |
Retained Earnings | -1,601 | -1,218 | -920 | -562 | -511 |
Comprehensive Income & Other | 95 | 48 | 21 | 9 | -1 |
Shareholders' Equity | 4,070 | 4,370 | 4,604 | 4,870 | 4,850 |
Total Liabilities & Equity | 4,218 | 4,502 | 4,932 | 5,101 | 4,943 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Cash (Debt) | 3,698 | 4,398 | 4,846 | 5,048 | 4,904 |
Net Cash Growth | -15.92% | -9.25% | -4.00% | 2.94% | 201.60% |
Net Cash Per Share | 219.49 | 261.90 | 290.30 | 307.76 | 333.99 |
Filing Date Shares Outstanding | 16.86 | 16.81 | 16.74 | 16.55 | 16.11 |
Total Common Shares Outstanding | 16.86 | 16.81 | 16.74 | 16.55 | 16.11 |
Working Capital | 3,880 | 4,337 | 4,577 | 4,861 | 4,848 |
Book Value Per Share | 241.37 | 259.94 | 275.06 | 294.25 | 301.11 |
Tangible Book Value | 3,982 | 4,354 | 4,596 | 4,863 | 4,850 |
Tangible Book Value Per Share | 236.15 | 258.98 | 274.58 | 293.83 | 301.11 |